Long COVID-19 syndrome associated with Omicron XBB.1.5 infection: a case report

Espíndola, Otávio; Resende, Paola C; Guaraldo, Lusiele; Calvet, Guilherme Amaral; Fuller, Trevon L; Penetra, Stephanie Lema Suarez; Santos, Heloisa Ferreira Pinto; Pina-Costa, Anielle; da Silva, Michele Fernanda Borges; Moraes, Isabella Campos Vargas; Medeiros, Fernando; Whitworth, Jimmy; Smith, Christopher; Nielsen-Saines, Karin; Siqueira, Marilda M; Brasil, Patrícia.
Mem. Inst. Oswaldo Cruz; 118: e230069, 2023. tab
Artigo em Inglês | LILACS-Express | ID: biblio-1514606

Documentos relacionados

  1. Long COVID-19 syndrome associated with Omicron XBB.1.5 infection: a case report.
  2. [Antibody Response After Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthcare Workers with and without Previous COVID-19 Infection: A Prospective Observational Study].
  3. Infection With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta Variant Is Associated With Higher Recovery of Infectious Virus Compared to the Alpha Variant in Both Unvaccinated and Vaccinated Individuals.
  4. [Multisystemic inflammatory syndrome in children after severe acute respiratory syndrome coronavirus 2 infection: a clinical analysis of four cases].
  5. Advances in the Omicron variant development.
  6. [Chronic hepatitis B virus infection: current and future treatment strategies].
  7. COVID-19 and the Immune Response: A Multi-Phasic Approach to the Treatment of COVID-19.
  8. Treatment of respiratory viral infections through inhalation therapeutics: Challenges and opportunities.
  9. Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike Protein.
  10. [Drug therapy interventions for acute SARS-CoV-2 infection: who, when, and what?]